Your browser doesn't support javascript.
loading
Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature.
Pala, Laura; Conforti, Fabio; Cocorocchio, Emilia; Ferrucci, Pierfrancesco; De Pas, Martino Tommaso; Stucchi, Sara; Repetto, Matteo; Saponara, Maristella; Queirolo, Paola.
  • Pala L; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Conforti F; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Cocorocchio E; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Ferrucci P; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • De Pas MT; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Stucchi S; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Repetto M; Research Nurses Team, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Saponara M; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Queirolo P; Department of Oncology and Haematology, University of Milan, Milan, Italy.
Cancer Invest ; 39(1): 9-14, 2021 Jan.
Article en En | MEDLINE | ID: mdl-33125301

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / SARS-CoV-2 / COVID-19 / Melanoma Límite: Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / SARS-CoV-2 / COVID-19 / Melanoma Límite: Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article